Editorial Commentary
Ivonescimab: promise or reality for advanced non-small cell lung cancer?
Translational Lung Cancer Research
2025;
14
(12)
:5203-5207
.
(31 December 2025)
Original Article
Real-world outcomes of trastuzumab deruxtecan as second- or further-line treatment in patients with HER2-mutant metastatic non-small cell lung cancer: a retrospective study
Translational Lung Cancer Research
2025;
14
(12)
:5208-5217
.
(31 December 2025)
Clinical characteristics of post-operative N2 nodal upstaging in non-small cell lung cancer: a retrospective cohort study
Translational Lung Cancer Research
2025;
14
(12)
:5218-5229
.
(31 December 2025)
Computer-aided quantitative stromal analysis: a comprehensive investigation of its prognostic significance in lung squamous cell carcinoma
Translational Lung Cancer Research
2025;
14
(12)
:5230-5242
.
(31 December 2025)
O-GlcNAcylation levels predict radiotherapy outcome in non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(12)
:5243-5256
.
(31 December 2025)
Patient-reported outcomes of radiofrequency ablation-video-assisted thoracoscopic surgery (VATS) hybrid surgery vs. uniportal VATS for multiple primary lung nodules: a longitudinal cohort study
Translational Lung Cancer Research
2025;
14
(12)
:5257-5272
.
(31 December 2025)
Additional 1.1-mm cryobiopsy trial guided by rapid on-site cytologic evaluation of touch imprint cytology result of small forceps biopsy in peripheral pulmonary lesions: a prospective single-center study
Translational Lung Cancer Research
2025;
14
(12)
:5273-5282
.
(31 December 2025)
Exon-level TP53 alterations and PD-L1 expression identified by pretreatment NGS stratify survival in EGFR-mutant non-small cell lung cancer treated with first-line osimertinib
Translational Lung Cancer Research
2025;
14
(12)
:5283-5295
.
(31 December 2025)
Development of a multimodal fully automated ensemble model to predict EGFR mutation and efficacy of EGFR-TKI in non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(12)
:5296-5304
.
(31 December 2025)
A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients
Translational Lung Cancer Research
2025;
14
(12)
:5305-5322
.
(31 December 2025)
Radiotherapy vs. photodynamic therapy: a comparison of antitumor effects and pulmonary toxicity in preclinical models
Translational Lung Cancer Research
2025;
14
(12)
:5323-5334
.
(31 December 2025)
Evaluating cancer risk profiles in lung transplant recipients
Translational Lung Cancer Research
2025;
14
(12)
:5335-5346
.
(31 December 2025)
Electromagnetic navigation bronchoscopy for localization of bilateral multiple pulmonary nodules: a comparative evaluation of safety and efficacy
Translational Lung Cancer Research
2025;
14
(12)
:5347-5356
.
(31 December 2025)
Exploring perioperative treatment for non-small cell lung cancer patients harboring EGFR mutation: a real-world multicenter cohort study
Translational Lung Cancer Research
2025;
14
(12)
:5357-5371
.
(31 December 2025)
Completion lobectomy following segmentectomy for malignant lung tumors: a multi-institutional study of surgical feasibility, oncologic outcomes, and diagnostic challenges (ESSG-02 study)
Translational Lung Cancer Research
2025;
14
(12)
:5372-5382
.
(31 December 2025)
Metabolic tumor volume on 18F-fluorodeoxyglucose uptake as prognostic marker for osimertinib in patients with non-small cell lung cancer harboring sensitive EGFR mutation
Translational Lung Cancer Research
2025;
14
(12)
:5383-5392
.
(31 December 2025)
Endocrine immune-related adverse events in advanced lung cancer patients receiving immune checkpoint inhibitors: incidence, predictors and outcomes
Translational Lung Cancer Research
2025;
14
(12)
:5393-5404
.
(31 December 2025)
Prognosis of segmentectomy and lobectomy for clinical T1c solid-dominant lung cancer
Translational Lung Cancer Research
2025;
14
(12)
:5405-5414
.
(31 December 2025)
Development and validation of an interpretable machine learning model for prediction of occult lymph node metastasis in clinical stage T1 lung adenocarcinoma
Translational Lung Cancer Research
2025;
14
(12)
:5415-5430
.
(31 December 2025)
Development and validation of machine learning models based on blood routine tests and tumor markers in early screening of primary bronchogenic lung cancer
Translational Lung Cancer Research
2025;
14
(12)
:5431-5446
.
(31 December 2025)
A lactylation-driven prognostic model for lung adenocarcinoma: cellular lactylation heterogeneity and immune insights
Translational Lung Cancer Research
2025;
14
(12)
:5447-5464
.
(31 December 2025)
Real-world outcomes of first-line immunotherapy and subsequent systemic therapies in pleural mesothelioma: a multicenter study in China
Translational Lung Cancer Research
2025;
14
(12)
:5465-5478
.
(31 December 2025)
The effects of neoadjuvant sintilimab versus pembrolizumab combined with chemotherapy on resectable non-small cell lung cancer: a multicenter propensity score-matched study
Translational Lung Cancer Research
2025;
14
(12)
:5479-5490
.
(31 December 2025)
Circulating tumor DNA as prognostic markers of non-small cell lung cancer (NSCLC): a systematic review and meta-analysis
Translational Lung Cancer Research
2025;
14
(12)
:5491-5508
.
(31 December 2025)
Review Article
Targeting ferroptosis to overcome drug resistance in lung cancer
Translational Lung Cancer Research
2025;
14
(12)
:5509-5526
.
(31 December 2025)
Study Protocol
A study protocol of a single-arm, prospective, open-label, non-controlled, phase II study of neoadjuvant BL-B01D1 combined with aumolertinib in resectable stage II–IIIB non-small cell lung cancer patients with EGFR mutation
Translational Lung Cancer Research
2025;
14
(12)
:5527-5534
.
(31 December 2025)
Case Report
Diagnostic challenge of systemic amyloidosis mimicking EGFR-TKI toxicity in lung adenocarcinoma: a case report
Translational Lung Cancer Research
2025;
14
(12)
:5535-5544
.
(31 December 2025)
Erratum
Erratum: Navigation of video-assisted thoracoscopic surgery using electromagnetic versus CT-guided localization (NOVEL): a study protocol for comparing procedural success and complication rates in a prospective, multicenter, randomized controlled, non-inferiority phase III trial
Translational Lung Cancer Research
2025;
14
(12)
:5545-5546
.
(31 December 2025)
